Is there a role of MMA T wave alternans test for risk assessment in Brugada syndrome?

References (4)

1. Yalın K, Gölcük E, Teker E, Bilge AK, Adalet K. Is there a role of MMA T wave alternans test for risk assessment in Brugada syndrome? Anadolu Kardiyol Derg 2013; 13: 702-4
2. Tada T, Kusano KF, Nagase S, Banba K, Miura D, Nishii N, et al. Clinical significance of macroscopic T-wave alternans after sodium channel blocker administration in patients with Brugada syndrome. J Cardiovasc Electrophysiol 2008; 19: 56-61
3. Uchimura-Makita Y, Nakano Y, Sairaku A, Tokuyama T, Fujiwara M, Watanabe Y, et al. Time-domain T-wave alternans in lead V2 is useful for predicting ventricular arrhythmias in patients with Brugada Syndrome [abstract]. Circulation 2013; 128: A16522
4. Verrier RL, Klingenheben T, Malik M, El-Sherif N, Exner D, Hohnloser S, et al. Microvolt T-wave alternans: Physiologic basis, methods of measurement, and clinical utility. Consensus guideline by the International Society for Holter and Noninvasive Electrocardiology. J Am Coll Cardiol 2011; 44: 1309-24. [CrossRef] 5. Morita H, Morita ST, Nagase S, Banba K, Nishii N, Tani Y, et al. Ventricular arrhythmia induced by sodium channel blocker in patients with Brugada syndrome. J Am Coll Cardiol 2003; 42: 1624-31. [CrossRef] 6. Priori SG, Wilde AA, Horie M, Cho Y, Behr ER, Berul C, et al. HRS/EHRA/ APHRS Expert Consensus Statement on the Diagnosis and Management of Patients with Inherited Primary Arrhythmia Syndromes. Heart Rhythm 2013; 10: 1932-63. [CrossRef] 7. Nishizaki M, Fujii H, Sakurada H, Kimura A, Hiraoka M. Spontaneous T wave alternans in a patient with Brugada syndrome-responses to intravenous administration of class I antiarrhythmic drug, glucose tolerance test, and atrial pacing. J Cardiovasc Electrophysiol 2005; 16: 217-20. [CrossRef] 8. Matsuo K, Kurita T, Inagaki M, Kakishita M, Aihara N, Shimizu W, et al. The circadian pattern of the development of ventricular fibrillation in patients with Brugada syndrome. Eur Heart J 1999; 20: 465-70. [CrossRef] 9. Kirchhof P Eckardt L, Rolf S, Esperer H-D, Paul M, Wichter T, et al. T wave alternans does not assess arrhythmic risk in patients with Brugada syndro- me. Ann Noninvasive Electrocardiol 2004; 9: 162-5. [CrossRef] 10. Ikeda T, Takami M, Sugi K, Mizusawa Y, Sakurada H, Yoshino H. Noninvasive risk stratification of subjects with a Brugada-type electrocardiogram and no history of cardiac arrest. Ann Noninvasive Electrocardiol 2005; 10: 396-403. [CrossRef]